FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to medicine and deals with composition with delayed release, which includes as active ingredient octreotide or its pharmaceutically acceptable salt and two or more different copolymers of polylactide and glycolide (PLGA), and said PLGA are present in form of mixture of polymers and at least two PLGAs are linear.
EFFECT: invention ensures considerable reduction of level of active ingredient fluctuation in plasma.
16 cl, 5 ex, 4 tbl
Authors
Dates
2012-10-27—Published
2006-12-20—Filed